TNGX - Tango Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$34.83
DETAILS
HIGH:
$55.00
LOW:
$24.00
MEDIAN:
$31.50
CONSENSUS:
$34.83
UPSIDE:
72.08%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 533,937 | $11.2M | 0.0% | -1,440,098 | DECREASED |
| Greenblatt | 19,137 | $400,346 | 0.0% | +19,137 | NEW |
| Laffont | 12,557 | $262,692 | 0.0% | +12,557 | NEW |
| Cooperman | 0 | $0 | -- | -1,025,553 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-01 | Crystal Adam | officer: President, R&D | M-Exempt | 27,000 | $5.20 | $140K |
| 2026-05-01 | Crystal Adam | officer: President, R&D | SELL | 1,100 | $22.00 | $24K |
| 2026-05-01 | Crystal Adam | officer: President, R&D | SELL | 25,900 | $21.19 | $549K |
| 2026-05-01 | Gall Matthew | officer: Chief Financial Officer | A-Award | 240,000 | $20.98 | $5.0M |
| 2026-05-01 | Gall Matthew | officer: Chief Financial Officer | A-Award | 40,000 | -- | -- |
| 2026-04-29 | Lee Sung | director | A-Award | 12,300 | -- | -- |
| 2026-04-29 | Lee Sung | director | A-Award | 5,200 | $22.06 | $115K |
| 2026-04-15 | Newcomb Jessica | officer: Principal Accounting Officer | ? | 153,094 | $11.94 | $1.8M |
| 2026-04-15 | Newcomb Jessica | officer: Principal Accounting Officer | ? | 2,000 | $2.67 | $5K |
| 2026-04-15 | Newcomb Jessica | officer: Principal Accounting Officer | ? | 74,295 | $12.28 | $912K |
| 2026-04-15 | Newcomb Jessica | officer: Principal Accounting Officer | ? | 126,188 | $2.91 | $367K |
| 2026-04-15 | Newcomb Jessica | officer: Principal Accounting Officer | ? | 1,000 | $8.93 | $9K |
| 2026-04-15 | Newcomb Jessica | officer: Principal Accounting Officer | ? | -- | -- | -- |
| 2026-04-15 | Newcomb Jessica | officer: Principal Accounting Officer | ? | 130,000 | $4.26 | $554K |
| 2026-04-15 | Newcomb Jessica | officer: Principal Accounting Officer | ? | 31,418 | $5.20 | $163K |
| 2026-04-15 | Newcomb Jessica | officer: Principal Accounting Officer | ? | 10,000 | $3.13 | $31K |
| 2026-04-15 | Gall Matthew | ? | -- | -- | -- | |
| 2026-04-15 | Crystal Adam | officer: President, R&D | M-Exempt | 38,460 | $5.20 | $200K |
| 2026-04-15 | Crystal Adam | officer: President, R&D | SELL | 38,460 | $25.00 | $962K |
| 2026-04-01 | Crystal Adam | officer: President, R&D | SELL | 27,000 | $21.20 | $572K |
| 2026-04-01 | Crystal Adam | officer: President, R&D | M-Exempt | 27,000 | $5.20 | $140K |
| 2026-03-25 | Crystal Adam | officer: President, R&D | SELL | 12,000 | $20.11 | $241K |
| 2026-03-25 | Crystal Adam | officer: President, R&D | M-Exempt | 12,000 | $5.20 | $62K |
| 2026-03-05 | Crystal Adam | officer: President, R&D | SELL | 20,251 | $15.00 | $304K |
| 2026-02-25 | Crystal Adam | officer: President, R&D | SELL | 54,345 | $12.77 | $694K |